Effects of substituents on anticancer activity of thiosemicarbazone against MCF-7 human breast cancer cell line
B. Z. Sibuh, P. Taneja, S. Khanna
This study evaluates the in-vitro anticancer activity of various thiosemicarbazones against MCF-7 breast cancer cells and normal MCF-10 cells, finding dose- and substituent-dependent effects with some compounds showing selectivity.
bioRxiv · Feb 19, 2020Cancer Biology